Skip to main content

Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure).

Publication ,  Journal Article
Parikh, KS; Lippmann, SJ; Greiner, M; Heidenreich, PA; Yancy, CW; Fonarow, GC; Hernandez, AF
Published in: Circulation
May 23, 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

May 23, 2017

Volume

135

Issue

21

Start / End Page

2077 / 2080

Location

United States

Related Subject Headings

  • Valsartan
  • Tetrazoles
  • Registries
  • Practice Guidelines as Topic
  • Middle Aged
  • Male
  • Humans
  • Hospitalization
  • Heart Failure
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Parikh, K. S., Lippmann, S. J., Greiner, M., Heidenreich, P. A., Yancy, C. W., Fonarow, G. C., & Hernandez, A. F. (2017). Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure). Circulation, 135(21), 2077–2080. https://doi.org/10.1161/CIRCULATIONAHA.117.027773
Parikh, Kishan S., Steven J. Lippmann, Melissa Greiner, Paul A. Heidenreich, Clyde W. Yancy, Gregg C. Fonarow, and Adrian F. Hernandez. “Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure).Circulation 135, no. 21 (May 23, 2017): 2077–80. https://doi.org/10.1161/CIRCULATIONAHA.117.027773.
Parikh KS, Lippmann SJ, Greiner M, Heidenreich PA, Yancy CW, Fonarow GC, et al. Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure). Circulation. 2017 May 23;135(21):2077–80.
Parikh, Kishan S., et al. “Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure).Circulation, vol. 135, no. 21, May 2017, pp. 2077–80. Pubmed, doi:10.1161/CIRCULATIONAHA.117.027773.
Parikh KS, Lippmann SJ, Greiner M, Heidenreich PA, Yancy CW, Fonarow GC, Hernandez AF. Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure). Circulation. 2017 May 23;135(21):2077–2080.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

May 23, 2017

Volume

135

Issue

21

Start / End Page

2077 / 2080

Location

United States

Related Subject Headings

  • Valsartan
  • Tetrazoles
  • Registries
  • Practice Guidelines as Topic
  • Middle Aged
  • Male
  • Humans
  • Hospitalization
  • Heart Failure
  • Female